- Funding Secured
- Posts
- Last Week's Top Funding Rounds
Last Week's Top Funding Rounds
Week over week declines across total fundraisings caused by...
Taylor Pierce
April 15, 2024
By Taylor Pierce - Monday, April 15
Funding Secured 101: Our weekly newsletter keeps investors informed about where capital is flowing across industries, while founders and businesses gain valuable intelligence on competitor funding and strategic investors.
Weekly Money Moves: Last week saw capital flow into a broader range of industries with more activity from Biotech, Real Estate, and Crpyto from a list of notable investors whom we have identified below.
Which sector do you think will attract the most capital this week?
Last week marked another downturn in overall fundraising, with the total amount decreasing from $1.9 billion to $1.1 billion. Despite this decline, the biotech industry emerged as the leading sector, securing 55% of the total funds raised. Key players in the biotech space, including Nurix, Acrivon, and Eliem Therapeutics, led the charge within the overall sector which raised $634 million last week.
Real Estate followed closely behind, with Global Net Lease spearheading the sector with a strong $237 million refinancing and once again the Crypto sector made waves with a significant round / bought deal led by Canaccord for Galaxy Digital, totaling $125 million.
Notably, Kootaney Silver also secured $9 million Canadian in a nicely upsized round.
However, amidst these highlights, the overall sentiment suggests a slowdown in fundraising activities, likely influenced by global macroeconomic conditions and heightened tensions in the Middle East, reflected in the recent WoW decline across the Dow Jones and S&P 500 indices.
Company | Money Raised ($USD) | Sector |
Global Net Lease | $237,000,000 | Real Estate |
Nurix Therapeutics | $175,000,000 | Biotechnology |
Acrivon Therapeutics | $130,000,000 | Biotechnology |
Galaxy Digital | $125,000,000 | Crypto |
Eliem Therapeutics | $120,000,000 | Biotechnology |
Century Therapeutics | $60,000,000 | Biotechnology |
Oculis | $59,000,000 | Biotechnology |
Leap Therapeutics | $40,000,000 | Biotechnology |
Dolphin Drilling | $39,847,693 | Oil & Gas |
PLAY | $32,069,555 | Transportation |
OncoCyte | $15,800,000 | Biotechnology |
Revolution Bars Group PLC | $15,668,794 | Restaurants |
Velo3D | $12,000,000 | Technology |
RenovoRx | $11,100,000 | Biotechnology |
HydrogenPro | $7,754,054 | Energy |
Kootenay Silver | $6,630,347 | Metals & Mining |
Rallybio | $6,600,000 | Biotechnology |
Ascent Solar Technologies | $6,000,000 | Energy |
Windar Photonics | $5,481,076 | Energy |
Longeveron | $5,250,000 | Biotechnology |
Revival Gold | $5,160,217 | Metals & Mining |
Aeries Technology Group | $5,000,000 | Technology |
Aptevo Therapeutics | $4,600,000 | Biotechnology |
NeuroSense Therapeutics | $4,500,000 | Biotechnology |
Premier American Uranium | $3,652,601 | Metals & Mining |
Lahontan Gold | $3,000,000 | Metals & Mining |
Cloud DX | $2,800,000 | Health Care |
Goldstone Resources | $2,307,629 | Metals & Mining |
VBI Vaccines | $2,000,000 | Biotechnology |
Carbon Done Right | $1,548,065 | Metals & Mining |
Quadrise Fuels International plc | $1,245,699 | Oil & Gas |
Vortex Metals | $1,059,263 | Metals & Mining |
Renalytix AI | $1,000,000 | Biotechnology |
Notable investors: Bain Capital Life Sciences led Century Therapeutics' $60 million offering, showcasing confidence in life sciences innovation. Johnson & Johnson Innovation spearheaded Rallybio's $6.6 million offering, emphasizing support for breakthrough therapies. DB Capital backed Renalytix AI with a $1 million investment, recognizing the potential of AI in healthcare diagnostics. Andritz took the lead in HydrogenPro's $7.7 million round, highlighting growing interest in clean energy solutions.
Forwarded this newsletter? → Get access to exclusive insights and join a prestigious community of top professionals in the finance industry. Subscribe now to receive a weekly snapshot of valuable fundraising data directly in your inbox.
Our subscribers are from…
